Document ID: chunk:federal_register_of_legislation:F2021L01401:reg:9:p1
Version: federal_register_of_legislation:F2021L01401
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 3861–6787

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the pancreas or death from malignant neoplasm of the pancreas with the circumstances of a person's relevant service:
(1)          having smoked tobacco products:
(a)          in an amount of at least 10 pack-years before the clinical onset of malignant neoplasm of the pancreas; and
(b)          commencing at least 5 years before the clinical onset of malignant neoplasm of the pancreas; and
if smoking has ceased before the clinical onset of malignant neoplasm of the pancreas, then that onset occurred within 20 years of cessation;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(2)          the oral use of smokeless tobacco:
(a)           on more days than not; and
(b)          for at least 20 years before the clinical onset of malignant neoplasm of the pancreas; and
if the oral use of smokeless tobacco has ceased before the clinical onset of malignant neoplasm of the pancreas, then that onset occurred within 20 years of cessation;
         Note: smokeless tobacco is defined in the Schedule 1 - Dictionary.
(3)          being overweight or obese for at least 5 years within the 30 years before the clinical onset of malignant neoplasm of the pancreas;
         Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
(4)          having diabetes mellitus for at least 5 years before the clinical onset of malignant neoplasm of the pancreas;
(5)          having chronic pancreatitis for at least 2 years before the clinical onset of malignant neoplasm of the pancreas;
(6)          having acute pancreatitis at least 2 years before the clinical onset of malignant neoplasm of the pancreas;
(7)          inhaling, ingesting or having cutaneous contact with DDT:
(a)           for a cumulative period of at least 1,000 hours before the clinical onset of malignant neoplasm of the pancreas; and
(b)          where the first exposure occurred at least 5 years before the clinical onset of malignant neoplasm of the pancreas;
               Note: DDT and inhaling, ingesting or having cutaneous contact with DDT are defined in the Schedule 1 - Dictionary.
(8)          undergoing a partial gastrectomy at least 20 years before the clinical onset of malignant neoplasm of the pancreas;
(9)          having received ionising radiation to the pancreas, from internal deposition of a therapeutic or diagnostic substance which emits alpha particles, at least 5 years before the clinical onset of malignant neoplasm of the pancreas;
            Note: An example of a therapeutic or diagnostic substance which emits alpha particles is thorium dioxide which is the main component of the radiocontrast agent Thorotrast, used during the 1930s - 1950s.
(10)      having cholelithiasis or having